These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20304704)

  • 1. Proteomic approaches in the search for biomarkers of liver fibrosis.
    Cowan ML; Rahman TM; Krishna S
    Trends Mol Med; 2010 Apr; 16(4):171-83. PubMed ID: 20304704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests.
    Gressner OA; Weiskirchen R; Gressner AM
    Clin Chim Acta; 2007 Jun; 381(2):107-13. PubMed ID: 17399697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical application of non-invasive diagnosis for hepatic fibrosis].
    Cho SW; Cheong JY
    Korean J Hepatol; 2007 Jun; 13(2):129-37. PubMed ID: 17585186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing liver fibrosis.
    Castera L
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):541-52. PubMed ID: 19072402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive measurement of liver fibrosis: application of the FibroScan in hepatology.
    Verveer C; de Knegt RJ
    Scand J Gastroenterol Suppl; 2006; (243):85-8. PubMed ID: 16782627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatic fibrosis: physiopathology and biological diagnosis].
    Housset C; Guéchot J
    Pathol Biol (Paris); 1999 Nov; 47(9):886-94. PubMed ID: 10609268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of liver fibrosis.
    Adams LA
    J Gastroenterol Hepatol; 2011 May; 26(5):802-9. PubMed ID: 21198831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive measures of liver fibrosis.
    Rockey DC; Bissell DM
    Hepatology; 2006 Feb; 43(2 Suppl 1):S113-20. PubMed ID: 16447288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of fibrosis in chronic liver diseases.
    Zhou K; Lu LG
    J Dig Dis; 2009 Feb; 10(1):7-14. PubMed ID: 19236541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive tools to assess liver disease.
    Patel K
    Curr Opin Gastroenterol; 2010 May; 26(3):227-33. PubMed ID: 20179592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive assessment of chronic liver and gastric diseases.
    Plebani M; Basso D
    Clin Chim Acta; 2007 May; 381(1):39-49. PubMed ID: 17374528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics in liver fibrosis is more than meets the eye.
    Cheung KJ; Tilleman K; Deforce D; Colle I; Van Vlierberghe H
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):450-64. PubMed ID: 18403948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis.
    Denzer UW; Lüth S
    Best Pract Res Clin Gastroenterol; 2009; 23(3):453-60. PubMed ID: 19505671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Liver fibrosis: pathophysiology, diagnosis and treatment].
    Pár A; Pár G
    Orv Hetil; 2005 Jan; 146(1):3-13. PubMed ID: 15715367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
    Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K
    Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.
    Castera L
    J Viral Hepat; 2009 May; 16(5):300-14. PubMed ID: 19254351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic biomarker discovery for the monogenic disease cystic fibrosis.
    Penque D
    Expert Rev Proteomics; 2007 Apr; 4(2):199-209. PubMed ID: 17425456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of liver fibrosis in clinical practice].
    Abenavoli L; Leggio L; Gasbarrini G; Addolorato G
    Recenti Prog Med; 2006 Sep; 97(9):481-5. PubMed ID: 17017301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy.
    Bedossa P
    Liver Int; 2009 Jan; 29 Suppl 1():19-22. PubMed ID: 19207962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.